Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women

Circulation

Volumn 100, Issue 12, 1999, Pages 1268-1273

  Roest, Mark ^b   Van Der Schouw, Yvonne T ^a   De Valk, Bart ^b   Marx, Jo J M ^b   Tempelman, Mariëlle J ^b   De Groot, Philip G ^b   Sixma, Jan J ^b   Banga, Jan Dirk ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

Atherosclerosis; Cardiovascular diseases; Cerebrovascular disorders; Genes genetics

Indexed keywords

CYSTEINE; DNA; IRON; TYROSINE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; FEMALE; GENE; GENE FREQUENCY; HEART INFARCTION; HEMOCHROMATOSIS; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; HYPERTENSION; IRON METABOLISM; MAJOR CLINICAL STUDY; MORTALITY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

EID: 0033592395     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.12.1268     Document Type: Article

References (30)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
2. Sullivan JL. The iron paradigm of ischemic heart disease. Am Heart J. 1989;117:1177-1188.
3. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992;86: 803-811.
4. Morrison HI, Semenciw RM, Mao Y, Wigle DT. Serum iron and risk of fatal acute myocardial infarction. Epidemiology. 1994;5:243-246.
5. Magnusson MK, Sigfusson N, Sigvaldason H, Johannesson GM, Magnusson S, Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation. 1994;89:102-108.
6. Frey GH, Krider DW. Serum ferritin and myocardial infarct. W V Med J. 1994;90:13-15.
7. Baer DM, Tekawa IS, Hurley LB. Iron stores are not associated with acute myocardial infarction. Circulation. 1994;89:2915-2918.
8. Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and the risk of coronary heart disease. N Engl J Med. 1994;330:1119-1124.
9. Cook JD, Finch CA, Smith NJ. Evaluation of the iron status of a population. Blood. 1976;48:449-455.
10. Baynes RD. Assessment of iron status. Clin Biochem. 1996;29:209-215.
11. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet. 1996; 13:399-408.
12. Roberts AG, Whatly SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the hemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet. 1997;349:321-323.
13. Santos M, Clevers HC, Marx JJM. Mutations of the hereditary hemochromatosis candidate gene HFE in porphyria cutanea tarda. N Engl J Med. 1997;336:1327-1328.
14. Mohler DN, Wheby MS. Hemochromatosis heterozygotes may have significant iron overload when they also have hereditary spherocytosis. Am J Med Sci. 1986;292:320-324.
15. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med. 1996;335:1799-1805.
16. Waard de F, Collette HJA, Rombach JJ, Baanders-van Halewijn EA, Honing C. The DOM project for the early detection of breast cancer, Utrecht, The Netherlands. J Chronic Dis. 1984;37:1-44.
17. Miettinen OS. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976;103:181-235.
18. Hardy GH. Mendelian proportions in a mixed population. Science. 1908; 28:41-50.
19. Weinberg W. On the demonstration of heredity in man. In: Boyer SH, ed. Papers on Human Genetics. Englewood Cliffs, NJ: Prentice-Hall; 1963.
20. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1995;19:251-253.
21. Huber PJ. The behavior of maximum likelihood estimates under non-standard conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. 1967;1:221-233.
22. Rothman KJ. Modern Epidemiology. Boston, Mass: Little, Brown & Co; 1986:61.
23. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet. 1981;1:1293-1294.
24. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis. 1993;23(suppl 1):118-126.
25. Gutteridge JMC. Iron promotors of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett. 1986;201:291-295.
26. Lamb DJ, Leake DS. Iron released from transferrin at acidic pH can catalyze the oxidation of low density lipoprotein. FEBS Lett. 1994;352: 15-18.
27. Baker E, Morgan EH. Iron transport. In: Brock JH, Halliday JW, Pippard MJ, eds. Iron Metabolism in Health and Disease. London, UK: WB Saunders; 1994:63-95.
28. Santos M, Schilham MW, Rademakers LHPM, Marx JJM, DeSousa M, Clevers H. Defective iron homeostasis in b2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. J Exp Med. 1996; 184:1975-1985.
29. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999; 353:1167-1173.
30. Tuomainen T-P, Kontula K, Nyyssönen K, Lakka TA, Heliö T, Salonen JT. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation. 1999;100:1274-1279.